MEDVi vs Remedy Meds

Both sell tirzepatide. MEDVi costs $399 a month and Remedy Meds costs $399. The desk reads it as follows.

MEDVi is tablet and injection choice. Remedy Meds is flat pricing with unlimited clinician access. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. MEDVi advertises $399 and bills $399; Remedy Meds advertises $279 and bills $399. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

They differ on 3 of the 7 things we track, and behave the same on the other 4. The differences are what the price gap is actually buying.

What each puts on the record: MEDVi

• Compounded tirzepatide injections listed at $399/month.
• Tirzepatide tablet pricing is quoted after the intake questionnaire rather than published up front.

Where it wins: Injection pricing is consistent between the first month and renewals. Watch for: You have to complete intake before seeing tablet pricing. Injection pricing is published at $399.

What each puts on the record: Remedy Meds

• Compounded semaglutide priced at $299/month flat, regardless of dose.
• Compounded tirzepatide priced at $399/month flat, regardless of dose.
• First month of tirzepatide discounted to $279, then $399/month.
• Medication is included in the monthly fee rather than billed separately.
• Unlimited clinician access, check-ins and dose adjustments included.
• Branded Zepbound offered at around $1,399/month.

Where it wins: Genuinely flat pricing — the dose can go to the top of the ladder without the bill moving. Watch for: The $279 introductory tirzepatide month renews at $399. Budget from the renewal figure.

In each one’s favour

MEDVi.

• Injection pricing is consistent between the first month and renewals.
• Tablet option for people who will not inject.

Remedy Meds.

• Genuinely flat pricing — the dose can go to the top of the ladder without the bill moving.
• Unlimited clinician access is included rather than sold as an upgrade.

How they score

Remedy Meds scores higher overall at 3.5 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

The desk’s call

• Pick MEDVi if cost is the binding constraint. Over a year the gap is about $0, which is real money for the same class of medication.
• Pick Remedy Meds if what it does better matters to you — genuinely flat pricing — the dose can go to the top of the ladder without the bill moving.
• Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

On the board, MEDVi at $399 a month is the more defensible choice on arithmetic alone. Remedy Meds earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: MEDVi and Remedy Meds.

How they sit against everyone else